Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Gyre Therapeutics Inc. (GYRE) SEC filings
Gyre Therapeutics Inc. (GYRE) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported GYRE revenue for 2025-12-31 was $116.6M. Net income was $9.9M. Revenue was up 10.2% from 2024-12-31 to 2025-12-31. GYRE currently screens at market cap $589.9M. The GYRE filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Gyre Therapeutics Inc. said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for GYRE — what management said, what changed, and why it matters.
Recent filings
GYRE SEC filings FAQ
What is the latest GYRE SEC filing?
The latest cached Gyre Therapeutics Inc. (GYRE) filing on this page is 8-K · Sep 1, 2026. Filings: https://lician.com/sec/gyre
What is the latest GYRE filing accession number?
The latest cached Gyre Therapeutics Inc. (GYRE) accession number on this page is 0001140361-26-035189. Filing: https://lician.com/sec/gyre/0001140361-26-035189
Which item codes are on the latest GYRE filing?
Cached item codes on the latest Gyre Therapeutics Inc. (GYRE) 8-K are 7.01, 9.01.
How many GYRE SEC filings are listed on this page?
This page lists 5 cached Gyre Therapeutics Inc. (GYRE) SEC filings. Filings: https://lician.com/sec/gyre
What events are listed on the GYRE SEC page?
Cached event headlines on this Gyre Therapeutics Inc. (GYRE) SEC page: "GYRE earnings". Events: https://lician.com/sec/gyre
What are GYRE's latest revenue and net income?
Latest cached Gyre Therapeutics Inc. (GYRE) revenue for Dec 31, 2025 was $116.6M. Net income was $9.9M. Statements: https://lician.com/financials/gyre